Could a $4 statin be the migraine cure We've been missing?

NCT ID NCT06248671

Recruiting now Disease control Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

First seen Feb 20, 2026 · Last updated Jun 06, 2026 · Updated 15 times

Summary

This study tests whether atorvastatin, a common cholesterol medicine, can prevent migraine attacks in adults with episodic migraine (4-14 attacks per month). Researchers will compare a 20mg dose, a 40mg dose, and a placebo over several months. The goal is to see if the drug reduces the number of migraine days and is safe, building on promising results from smaller studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Haukeland University Hospital
RECRUITING

Bergen, Norway

Contact Email: •••••@•••••
Oslo University Hospital, Rikshospitalet
NOT_YET_RECRUITING

Oslo, Norway

Contact Email: •••••@•••••
Oslo University Hospital, Ullevål
NOT_YET_RECRUITING

Oslo, Norway

Contact Email: •••••@•••••
St. Olavs hospital
RECRUITING

Trondheim, 7022, Norway

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
University Hospital Northern Norway
RECRUITING

Tromsø, Norway

Contact Email: •••••@•••••
University Hospital, Akershus
NOT_YET_RECRUITING

Lørenskog, Norway

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

EPISODIC MIGRAINE